TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.315
+0.065 (2.89%)
Mar 9, 2026, 3:33 PM EDT - Market open
TherapeuticsMD Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 27 | 10 | 26 | 53 | 151 | 358 | |
| Market Cap Growth | 130.99% | -61.51% | -51.31% | -64.97% | -57.86% | -45.38% | |
| Enterprise Value | 25 | 12 | 24 | 148 | 241 | 527 | |
| Last Close Price | 2.25 | 0.86 | 2.25 | 5.59 | 17.77 | 60.50 | |
| PE Ratio | 86.23 | - | - | 0.47 | - | - | |
| PS Ratio | 9.31 | 5.63 | 19.79 | 0.76 | 58.71 | 5.53 | |
| PB Ratio | 0.95 | 0.36 | 0.88 | 1.51 | -1.61 | -2.89 | |
| P/TBV Ratio | 1.11 | 0.43 | 1.11 | 1.88 | - | - | |
| P/FCF Ratio | 12.59 | 13.55 | - | - | - | - | |
| P/OCF Ratio | 12.59 | 13.55 | - | - | - | - | |
| EV/Sales Ratio | 9.09 | 6.97 | 18.28 | 2.12 | 93.74 | 8.13 | |
| EV/EBITDA Ratio | - | - | - | 12.49 | - | - | |
| EV/EBIT Ratio | - | - | - | 13.89 | - | - | |
| EV/FCF Ratio | 12.29 | 16.76 | - | - | - | - | |
| Debt / Equity Ratio | 0.24 | 0.26 | 0.27 | 0.25 | -2.11 | -2.00 | |
| Debt / EBITDA Ratio | - | - | - | 0.63 | - | - | |
| Debt / FCF Ratio | 3.14 | 9.80 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.02 | 0.08 | 0.13 | -0.83 | -1.42 | -1.36 | |
| Net Debt / EBITDA Ratio | 0.48 | -0.71 | -0.45 | -2.47 | -1.87 | -1.12 | |
| Net Debt / FCF Ratio | -0.31 | 2.89 | -0.08 | 7.19 | -0.93 | -1.05 | |
| Asset Turnover | 0.07 | 0.04 | 0.02 | 0.54 | 0.02 | 0.29 | |
| Inventory Turnover | - | - | - | - | - | 1.61 | |
| Quick Ratio | 2.18 | 1.67 | 1.08 | 0.81 | 0.26 | 1.91 | |
| Current Ratio | 2.93 | 2.37 | 1.72 | 1.18 | 0.47 | 2.17 | |
| Return on Equity (ROE) | 0.27% | -8.16% | -23.90% | - | - | - | |
| Return on Assets (ROA) | -2.73% | -5.32% | -7.96% | 5.13% | -25.48% | -43.12% | |
| Return on Capital Employed (ROCE) | -5.10% | -10.40% | -23.40% | 24.40% | 85.80% | -126.20% | |
| Earnings Yield | 1.16% | -21.99% | -39.89% | 211.63% | -114.14% | -51.20% | |
| FCF Yield | 7.94% | 7.38% | -186.82% | -7.71% | -94.48% | -44.55% | |
| Buyback Yield / Dilution | -1.31% | -10.45% | -11.48% | -17.66% | -44.39% | -11.89% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.